Latest / Pharmacy Podcast Network / The NASP Specialty Pharmacy Expo RECAP Show | Part One

Transcript

The NASP Specialty Pharmacy Expo RECAP Show | Part One · Pharmacy Podcast Network

• 0:05
  Speaker 1: You are listening to the global network of podcasters dedicated
• 0:09
  Speaker 1: to the pharmacy profession. Welcome to the Pharmacy Podcast Network.
• 0:24
  Speaker 2: Hey there, welcome to the NASP twenty twenty five here
• 0:32
  Speaker 2: at the gay Lord Rockies in Denver, Colorado. This is
• 0:35
  Speaker 2: an exciting time where we're bringing together thousands of people
• 0:40
  Speaker 2: focused on specialty pharmacy and impact on our patients.
• 0:44
  Speaker 3: You're not going to want to miss this.
• 0:45
  Speaker 2: Stay tuned for the coverage of the NASP twenty twenty five,
• 0:50
  Speaker 2: brought to you by the Pharmacy Podcast Network.
• 0:55
  Speaker 4: Hi, this is Christine tang Wilson, VP of Strategy with
• 0:58
  Speaker 4: Lumis Earra House Services, and you're listening to the NASP podcast.
• 1:03
  Speaker 2: Hey, my friend Shawn Jensen and JB Consulting is sponsoring
• 1:07
  Speaker 2: our NASP podcast this year.
• 1:10
  Speaker 3: Sean, thank you so much for being here. Oh, we're
• 1:12
  Speaker 3: so happy to be here. Todd, thanks for being here too.
• 1:14
  Speaker 2: What's the importance of being part of the NSP, Sean,
• 1:17
  Speaker 2: why do you invest You've put a lot of time
• 1:19
  Speaker 2: into this organization and you believe in the organization.
• 1:23
  Speaker 3: What's it important? Why is it important to be here?
• 1:24
  Speaker 5: Oh?
• 1:25
  Speaker 3: I love this organization.
• 1:26
  Speaker 6: I mean Sheilin team do such a great job, and
• 1:28
  Speaker 6: there's really no place to bring the specialty pharmacy community
• 1:31
  Speaker 6: together for the networking, the information exchange. You know, you
• 1:35
  Speaker 6: think of a SMBA and the speed dating scene and
• 1:37
  Speaker 6: you can see hundreds of people a day, but here
• 1:39
  Speaker 6: you can really enjoy the sessions. You can sit and
• 1:41
  Speaker 6: spend time talking to people. I find like the quality
• 1:44
  Speaker 6: of the connections and the quality of the sessions is
• 1:46
  Speaker 6: so high here in NEESP.
• 1:48
  Speaker 2: Christine, your organization's very special to then Pharmacy Podcast Network.
• 1:52
  Speaker 2: You've supported us for years. Loomas Sarah Health Services really
• 1:56
  Speaker 2: stands out. Matter of fact, Eric was one of the
• 2:00
  Speaker 2: fifty most influential pharmacists in I think it was twenty
• 2:03
  Speaker 2: twenty three or twenty twenty four, losing count I think exactly.
• 2:07
  Speaker 2: But talk to us about your position with loumis Era
• 2:11
  Speaker 2: and what you're doing in specialty pharmacy.
• 2:13
  Speaker 4: Absolutely so again, I'm Christine tang Wilson. I'm the vice
• 2:16
  Speaker 4: president of Strategy with Lumisarrah Health Services and really what
• 2:19
  Speaker 4: that means is under me, I have the technology organization,
• 2:23
  Speaker 4: I have the product organization.
• 2:25
  Speaker 7: Very importantly as you'll have the.
• 2:26
  Speaker 4: Strategic planning and delivery organization as well as quality training accreditations.
• 2:31
  Speaker 4: So really my organization represents that glue that is extremely
• 2:35
  Speaker 4: important to connect the sales and business development side that
• 2:38
  Speaker 4: Eric Hugkins, my peer represents, but also the operation side
• 2:42
  Speaker 4: that my VP of Operations you know, represent where kind
• 2:44
  Speaker 4: of the three musketeers, if you will, and we work
• 2:48
  Speaker 4: really well together in terms of delivering excellent service to
• 2:51
  Speaker 4: our patients.
• 2:51
  Speaker 2: At the end of the day, Sean, it's exciting that
• 2:54
  Speaker 2: you're teaming up with Loumis Sarrah. You and I a
• 2:58
  Speaker 2: little bit of our science fiction nerdy and I always
• 3:01
  Speaker 2: think of where AI is taking us kind of apply
• 3:03
  Speaker 2: that to this conversation and working with lumis Era.
• 3:07
  Speaker 3: Well just I mean I think of Loumis Sarah.
• 3:09
  Speaker 6: I mean, obviously they're the some of the nicest and
• 3:11
  Speaker 6: smartest group of people in the industry, but just in
• 3:14
  Speaker 6: terms of technology, I mean, this team is really at
• 3:16
  Speaker 6: the front of the you know, their forefront, and they've
• 3:18
  Speaker 6: always have been. I mean, they have a lot of
• 3:20
  Speaker 6: their own platforms, they integrate a lot of their systems,
• 3:22
  Speaker 6: I mean, to such a unique approach to how they
• 3:24
  Speaker 6: do technology in the specialty space and with AI, I
• 3:28
  Speaker 6: mean it just positions you guys to be able to
• 3:30
  Speaker 6: do so much than just buying what's off the shelf.
• 3:33
  Speaker 6: I mean having an IT team having all these capabilities.
• 3:36
  Speaker 6: I mean it's like this, Skuy's really the limit.
• 3:37
  Speaker 8: With an organization like this.
• 3:39
  Speaker 7: Thank you Sean for saying that. You know, I'm honored
• 3:42
  Speaker 7: to hear that.
• 3:42
  Speaker 4: And really, as I think about, you know, in this case,
• 3:45
  Speaker 4: technology and AI and what it can do for organization
• 3:48
  Speaker 4: like lumis Era, I really think about us approaching this
• 3:51
  Speaker 4: in a couple of different ways. I think fundamentally, technology
• 3:54
  Speaker 4: is there to help us be user centric, to help us,
• 3:57
  Speaker 4: you know, really exemplify our mission in terms is serving,
• 4:00
  Speaker 4: at the end of the day, our patients in the
• 4:02
  Speaker 4: best possible, most human possible.
• 4:04
  Speaker 7: Way to make sure they get the medications they need.
• 4:07
  Speaker 4: In this case, oftentimes they're life saving medications, right. And
• 4:11
  Speaker 4: so when I think about AI, one of the ways
• 4:14
  Speaker 4: that we think about it also is how do we
• 4:16
  Speaker 4: make sure that we maintain our world class MPs right
• 4:21
  Speaker 4: while using technology tools.
• 4:23
  Speaker 7: Like AI to really help make us do our.
• 4:25
  Speaker 4: Work better without losing that human centric, user centric, you know,
• 4:31
  Speaker 4: fundamental kind of starting point. Because at the end of
• 4:34
  Speaker 4: the day, it's a tool and it doesn't replace, you know,
• 4:37
  Speaker 4: the warmth and the kindness that our PCAs exhibit every
• 4:40
  Speaker 4: single day on every single call. And that is why
• 4:42
  Speaker 4: we have ninety three percent you know in higher OSAT
• 4:46
  Speaker 4: score you know as of this last year, and more
• 4:48
  Speaker 4: than eighty one you know MPs, and so we take
• 4:52
  Speaker 4: absolute pride in that. And when we look at AI,
• 4:54
  Speaker 4: we look at how it can augment some of our
• 4:56
  Speaker 4: work cloths again to help us get closer.
• 4:59
  Speaker 7: And more fish to our patients.
• 5:01
  Speaker 4: But it doesn't replace that human element and that human
• 5:04
  Speaker 4: connectedness that we're so well known for, Sean.
• 5:08
  Speaker 2: It's putting AI where it needs to be to get
• 5:11
  Speaker 2: a lot of menial tasks and things that are happening
• 5:14
  Speaker 2: in the specialty pharmacy to get them out of the
• 5:16
  Speaker 2: way from a data perspective, allowing that specialty pharmacists to
• 5:20
  Speaker 2: dial into precision care for the patient who's desperate to
• 5:23
  Speaker 2: me a little bit more of that human, human touch
• 5:26
  Speaker 2: and the guidance. I think of our specialty pharmacist as
• 5:29
  Speaker 2: advocates of the treatment plan and being able to communicate
• 5:33
  Speaker 2: to the electronic health record and the physician that's in
• 5:35
  Speaker 2: charge and dialing into what are the barriers that these
• 5:38
  Speaker 2: people are facing with a disease state that it's chronic,
• 5:42
  Speaker 2: it's a problem, it's pressuring their family life, it's pressuring
• 5:45
  Speaker 2: their quality of life.
• 5:48
  Speaker 3: Loumisara has dialed into that.
• 5:49
  Speaker 2: I've had so many conversations with your team, Christine, to
• 5:52
  Speaker 2: expand upon what it means to be a true provider
• 5:56
  Speaker 2: of a specialty care that you know this because you've
• 5:59
  Speaker 2: done it oh over and over and over, so that
• 6:01
  Speaker 2: that patient that it's new to them and they're getting
• 6:04
  Speaker 2: on medication and they're having to stay adherent because of
• 6:07
  Speaker 2: how sensitive it is and how expensive it is. Christine
• 6:10
  Speaker 2: talked to us a little bit more about how Louma
• 6:12
  Speaker 2: Sarah has removed barriers for care and follow up.
• 6:16
  Speaker 4: Yeah, thank you for that. You actually mentioned a couple
• 6:18
  Speaker 4: of things that are really important. One of them is data,
• 6:21
  Speaker 4: which I'd like to come back to in just a second.
• 6:23
  Speaker 4: But in terms of just engaging with our patients, I
• 6:25
  Speaker 4: think people have said this, but I do believe in it,
• 6:27
  Speaker 4: and that is really meeting them where they are. And
• 6:30
  Speaker 4: I think in this day and age that digital customer
• 6:33
  Speaker 4: engagement cannot be underestimated and we allow different modes of
• 6:37
  Speaker 4: access into our interactions, you know, in terms of how
• 6:41
  Speaker 4: patients can choose to either two way texas, can choose
• 6:44
  Speaker 4: to interact with us on the portal, can choose to
• 6:46
  Speaker 4: call in you know, different modes if you will, different
• 6:49
  Speaker 4: channels of access.
• 6:50
  Speaker 7: And I think that's really important.
• 6:52
  Speaker 4: But coming back to the data point you mentioned, and
• 6:54
  Speaker 4: this is something that we're actively investing in. Is I
• 6:57
  Speaker 4: think with every system you're talking about also really at
• 7:00
  Speaker 4: the end of the day, is how they interact, the
• 7:02
  Speaker 4: interaction and the flow between the data pieces between different systems,
• 7:06
  Speaker 4: different data marks, how they interact in order to form
• 7:09
  Speaker 4: a holistic picture of our patients at the end of
• 7:11
  Speaker 4: the day, so we can better serve them. And that
• 7:13
  Speaker 4: data infrastructure piece is something that we're actively investing in
• 7:17
  Speaker 4: in order to have the appropriate extraction layers and orchestration
• 7:21
  Speaker 4: layers so that we can form a holistic picture, a
• 7:25
  Speaker 4: single source of truth for our patients that would allow
• 7:28
  Speaker 4: U was then to better orchestrate these digital based interactions
• 7:32
  Speaker 4: at the end of the day.
• 7:33
  Speaker 7: So it's something that's you.
• 7:35
  Speaker 4: Know, really near and dear to my heart and again
• 7:37
  Speaker 4: you know, with me joining them this air in January
• 7:39
  Speaker 4: I'm putting a very definitive kind of vision around this
• 7:42
  Speaker 4: and that we're actively investing in it in order to
• 7:45
  Speaker 4: make that, you know, a reality in twenty twenty six.
• 7:48
  Speaker 3: That's awesome, I know.
• 7:50
  Speaker 6: I mean, Lumisara always puts the patient first, as you
• 7:52
  Speaker 6: know everybody knows. But one thing I find is talking
• 7:55
  Speaker 6: to other vendors and other you know, tech companies, whenever
• 7:58
  Speaker 6: lumis Sarah comes up, you'll always hear positive things in
• 8:01
  Speaker 6: terms of you know, they're easy to work with, They're
• 8:03
  Speaker 6: so like, you know, everything's always so positive. I don't
• 8:06
  Speaker 6: know what the secret sauces here, Christine, but why do
• 8:08
  Speaker 6: everyone always say both patients and vendors and everyone, it
• 8:10
  Speaker 6: seems like everyone loves working with Lumisa Thanks for the
• 8:13
  Speaker 6: reason for that, you know, I think it is our people.
• 8:16
  Speaker 7: I think truly our people care. They care deeply.
• 8:19
  Speaker 4: It's not just a job to them, and you know,
• 8:22
  Speaker 4: you see the impact that those men have on our
• 8:24
  Speaker 4: patients' daily lives, and it's something that touches all of us.
• 8:27
  Speaker 4: I think we've all had interactions where the health system
• 8:31
  Speaker 4: kind of the healthcare system kind of feeled us in
• 8:33
  Speaker 4: a way, right, And so we can all take those
• 8:36
  Speaker 4: personal learnings and I think a crew at Lumisa, I
• 8:38
  Speaker 4: would say, are small but mighty crew. You know, of
• 8:42
  Speaker 4: roughly between five and six hundred employees. We care deeply
• 8:45
  Speaker 4: every single one of us, and I think that's what drives.
• 8:47
  Speaker 7: Us every day.
• 8:48
  Speaker 3: That's awesome. Like I said, there's some of the nicest
• 8:50
  Speaker 3: people in the business. Everyone knows that. I don't know
• 8:53
  Speaker 3: what it is about Lumisara, but it's the water. It's Wisconsin.
• 8:59
  Speaker 2: Hey, stay tuned for more of the NSP podcast.
• 9:03
  Speaker 3: We will be right back.
• 9:09
  Speaker 9: Hi.
• 9:09
  Speaker 7: This is Amanda aw.
• 9:10
  Speaker 10: I am the director of Pharmacy Products and Solutions at VPL,
• 9:14
  Speaker 10: and you're listening to the NESP.
• 9:16
  Speaker 2: Podcast Special Tradition here at the NASP. And now it's
• 9:22
  Speaker 2: the twenty twenty five Doctor Amanda ah is back?
• 9:26
  Speaker 3: Is this year or what? What are we on? Three?
• 9:29
  Speaker 7: I think this is the third time.
• 9:31
  Speaker 2: Yeah, triple all right, Well, I always enjoy talking with
• 9:35
  Speaker 2: you bring us a lot of insights. You actually did
• 9:38
  Speaker 2: a session at NESP that was dialing into safety within
• 9:43
  Speaker 2: the last mile and how important that's becoming from a
• 9:46
  Speaker 2: multitude of issues including temperature and timing and anything that
• 9:50
  Speaker 2: kind of goes into the drug therapy.
• 9:53
  Speaker 3: Talk to us about that.
• 9:54
  Speaker 10: Yeah, we were so excited to get selected. There's a
• 9:58
  Speaker 10: medication safety track as far as education sessions are concerned,
• 10:03
  Speaker 10: but this was the first year that we had a
• 10:05
  Speaker 10: topic selected, which I think is speaks volumes. It says
• 10:08
  Speaker 10: that as an industry NASP rights, as the industry leaders,
• 10:13
  Speaker 10: they're they're noticing that we need to have more dialogue
• 10:17
  Speaker 10: surrounding errors that happened in the last mile.
• 10:19
  Speaker 3: Okay, right, last mile.
• 10:21
  Speaker 10: A lot of times gets kind of shoved out into
• 10:25
  Speaker 10: the corner and sort of labeled as, oh, that's kind
• 10:29
  Speaker 10: of back office logistics.
• 10:30
  Speaker 7: You know, it's not clinical.
• 10:32
  Speaker 10: But I've spent the last few years trying to trying
• 10:35
  Speaker 10: to change that sort of perception because I think it is.
• 10:39
  Speaker 10: It's clinically adjacent. It's it's right there. And so in
• 10:43
  Speaker 10: order for pharmacies to have the tools that they need
• 10:46
  Speaker 10: to be able to serve their patients in the right way,
• 10:48
  Speaker 10: you need these tools that are adjacent to your clinical
• 10:51
  Speaker 10: upstream workflows and delivery. Software that addresses medication safety is
• 10:57
  Speaker 10: one of those things.
• 10:58
  Speaker 3: Amanda.
• 10:59
  Speaker 2: I'm using my non pharmacist brain in my imagination, which
• 11:04
  Speaker 2: is pretty crazy. I'm thinking of manufacturers wanting to build
• 11:10
  Speaker 2: trusted relationships with specialty pharmacies and how certain reporting is required.
• 11:16
  Speaker 2: Obviously there's documentation that might be drawn back into how
• 11:21
  Speaker 2: well they're doing from a compliance perspective. How does this
• 11:26
  Speaker 2: tie into that that data that the manufacturer's worried about.
• 11:31
  Speaker 10: Yeah, to be completely transparent, I think we're still a
• 11:35
  Speaker 10: little ways off from that. We are still kind of
• 11:38
  Speaker 10: at the pharmacy's level, right, trying to trying to communicate
• 11:46
  Speaker 10: to them how important that is. But yes, our theory
• 11:50
  Speaker 10: you hit the nail on the head. Our theory is
• 11:52
  Speaker 10: that we can make their patient experience better, we can
• 11:56
  Speaker 10: make our provider experiences better, and then they can take
• 11:59
  Speaker 10: that and translate that to hey, this is why we're
• 12:02
  Speaker 10: doing this, is why we deserve this contract. This is
• 12:04
  Speaker 10: why you know we are the best in the in
• 12:07
  Speaker 10: the region at what we do.
• 12:08
  Speaker 3: You know so and so forth.
• 12:11
  Speaker 2: All Right, So I'm listening in. I'm a pharmacy that's
• 12:15
  Speaker 2: out there, I'm working. This has been an issue for me.
• 12:18
  Speaker 2: How do I reach out to you to get us
• 12:20
  Speaker 2: to do like a follow up conversation or a meeting.
• 12:23
  Speaker 10: Yeah, the best way, I guess is just my email
• 12:26
  Speaker 10: a Awe at vpmail dot com.
• 12:29
  Speaker 3: Excellent.
• 12:30
  Speaker 10: Yeah, but even just just from our website, you know,
• 12:33
  Speaker 10: I'm sure it'll get It'll get routed to me one
• 12:36
  Speaker 10: way or another.
• 12:36
  Speaker 3: So excellent.
• 12:37
  Speaker 2: Well make sure that we see you in Where are
• 12:41
  Speaker 2: we going to? Where are we in twenty twenty six?
• 12:43
  Speaker 2: It was just announced.
• 12:46
  Speaker 3: Is it back in DC?
• 12:47
  Speaker 2: Maryland? And in DC? And I get to drive there
• 12:51
  Speaker 2: this time. I'm not going to have to fly. It's
• 12:53
  Speaker 2: in my backyard from Pittsburgh.
• 12:54
  Speaker 7: Nice.
• 12:55
  Speaker 3: Aman, It's so good to see.
• 12:56
  Speaker 7: You you too, Thanks again.
• 13:02
  Speaker 11: Better patient outcomes start with the right technology partners. JB
• 13:06
  Speaker 11: Consulting helps pharmacies deliver superior clinical care and enhance patient
• 13:10
  Speaker 11: experiences through smart technology solutions. Our products help pharmaceutical manufacturers
• 13:14
  Speaker 11: improve patient access and build stronger pharmacy relationships. JB Consulting
• 13:20
  Speaker 11: Where pharmaceutical expertise meets cutting edge technology. Visitjbconsulting dot com.
• 13:30
  Speaker 2: Chris Corsi here at the NASP podcast talking to me
• 13:34
  Speaker 2: about something that is one of the biggest subjects here.
• 13:38
  Speaker 2: It starts with A, it ends with I, and it's
• 13:40
  Speaker 2: the mysterious monster of the ecosystem.
• 13:44
  Speaker 3: Right now, Chris, how you doing.
• 13:46
  Speaker 12: I'm doing great, great to be out here at ASP.
• 13:48
  Speaker 12: It's a very vibrant and it's been busier than it's
• 13:51
  Speaker 12: ever been.
• 13:51
  Speaker 13: So it is.
• 13:53
  Speaker 3: This is a record setting year.
• 13:54
  Speaker 2: It's over twenty one hundred participants versus nineteen hundred from
• 13:58
  Speaker 2: LASH one hundred people from last year. I'm excited about
• 14:03
  Speaker 2: where NASP is helping to take the pharmacy, especially pharmacy profession.
• 14:08
  Speaker 2: Why do you invest in ANASP, What do you like
• 14:10
  Speaker 2: about this organization and how does it apply to what
• 14:14
  Speaker 2: you do as for a living.
• 14:15
  Speaker 13: It's the community. We have the best community, I think
• 14:17
  Speaker 13: anywhere in any industry.
• 14:20
  Speaker 12: You have so many subject matter experts out here pitching ideas,
• 14:23
  Speaker 12: coming up with ways to improve patient outcomes and healthcare
• 14:27
  Speaker 12: and really help these people that really really need help
• 14:29
  Speaker 12: with these complex disease states. So that's what gets me excited.
• 14:33
  Speaker 12: That's why I keep coming out here than ASP every
• 14:35
  Speaker 12: year and hopefully we got more and more turnout. Let's
• 14:37
  Speaker 12: break three thousand next year.
• 14:38
  Speaker 2: Right, all right, Cassie and RX, you're making sense of
• 14:43
  Speaker 2: application to AI and how to apply it, how to
• 14:46
  Speaker 2: really bring a full solution in the way that you
• 14:50
  Speaker 2: were describing it to me, I'm not a pharmacist, certainly
• 14:54
  Speaker 2: not someone in the trenches, but explain to our listeners
• 14:57
  Speaker 2: what you're doing and how you're leveraging technology, g how
• 15:00
  Speaker 2: you're enleveraging artificial intelligence to really make a difference in
• 15:04
  Speaker 2: specialty pharmacy workflow.
• 15:05
  Speaker 13: Yeah, definitely. I think it was one of the talks today.
• 15:08
  Speaker 12: They were talking about everybody has an AI solution for
• 15:11
  Speaker 12: a thing, right, whether it's for bivv PA processing right
• 15:15
  Speaker 12: as you keep going down, it's a solution and there's
• 15:18
  Speaker 12: ten people building a solution for this one thing. Well,
• 15:21
  Speaker 12: how do you integrate that into the workflow?
• 15:23
  Speaker 8: Right?
• 15:23
  Speaker 12: You have all these dispensing platforms and frankly a lot
• 15:26
  Speaker 12: of them don't want to be integration friendly with a
• 15:27
  Speaker 12: lot of other vendors. So at the end of the day,
• 15:30
  Speaker 12: it's how do you make the pharmacy and the physician
• 15:33
  Speaker 12: and the patient's life easier and how do you integrate
• 15:36
  Speaker 12: that together. So that's where Cassine has been spending time
• 15:39
  Speaker 12: and our ecosystem we've always been focused around building a
• 15:42
  Speaker 12: fully integrated and ecosystem for the pharmacy, for the physician,
• 15:46
  Speaker 12: for the patient, for the payer, and even for the manufacturer.
• 15:49
  Speaker 12: So how do you get those You know, all those
• 15:51
  Speaker 12: different stakeholders in the ecosystem have visibility to where the
• 15:54
  Speaker 12: patient's at in.
• 15:55
  Speaker 13: Their journey and improve outcomes overall.
• 15:58
  Speaker 12: So really that's where we've been focused our time and
• 16:01
  Speaker 12: building out different pieces of that ecosystem and that integration
• 16:04
  Speaker 12: layer I'll call it, right, that can sit above all
• 16:07
  Speaker 12: those solutions and be agnostic to whoever it might be,
• 16:10
  Speaker 12: whether that's pulling in different PA solutions, VII solutions, etc.
• 16:13
  Speaker 12: And leveraging AI so the pharmacy can really get that
• 16:17
  Speaker 12: operational efficiency or better outcome for the patient.
• 16:20
  Speaker 2: Chris, what's the common denominator though, because when you say
• 16:23
  Speaker 2: the word integration, I've been around pharmacy now twenty plus years.
• 16:29
  Speaker 2: I remember begging automation companies to build APIs between us
• 16:34
  Speaker 2: and our pharmacy management system.
• 16:37
  Speaker 3: Where's the common denominator for CASSI?
• 16:39
  Speaker 2: And where do you start so that you can have
• 16:43
  Speaker 2: kind of a baseline to say, Okay, this will give
• 16:46
  Speaker 2: us what we need to build something bigger.
• 16:48
  Speaker 12: Sure, Sure, I mean you start with the basics, right,
• 16:51
  Speaker 12: patient demographics, script demographic, all that time type.
• 16:55
  Speaker 13: Of just basic information.
• 16:56
  Speaker 12: Right, Let's extract that out and then figure it out.
• 16:59
  Speaker 13: How do we build the data layer?
• 17:00
  Speaker 12: Right, that's the key step is figuring out that data layer,
• 17:03
  Speaker 12: and it's.
• 17:03
  Speaker 13: A crawl walk wrong method. Right.
• 17:05
  Speaker 12: A lot of the pharmacies today don't have that data layer.
• 17:08
  Speaker 12: They have twenty systems that all have disparate data. So
• 17:13
  Speaker 12: let's get that data layer in place, and let's enable
• 17:15
  Speaker 12: the pharmacies to get that data layer and then take
• 17:17
  Speaker 12: the next step to start driving autonomous workflow, so leveraging
• 17:20
  Speaker 12: the data and then you know you're walking now right,
• 17:23
  Speaker 12: I have data I can take action on and I.
• 17:25
  Speaker 13: Can automate the workflow.
• 17:26
  Speaker 12: Then you get to an AI state of let's start
• 17:28
  Speaker 12: pattern recognizing different things within the workflow and then start
• 17:32
  Speaker 12: driving efficiency. So maybe an FRM doesn't need to come
• 17:34
  Speaker 12: in and say, hey, I need you to do this.
• 17:36
  Speaker 12: The system already did it right, or the pharmacies doesn't
• 17:39
  Speaker 12: need to review it and the system.
• 17:40
  Speaker 13: Already did it. So that's the end state.
• 17:42
  Speaker 12: But I don't even think from what I've seen and
• 17:44
  Speaker 12: what I've heard, and I've talked to people, most people
• 17:46
  Speaker 12: don't even have the crawl the data layer in place.
• 17:48
  Speaker 12: They sit there and they say, my dispensing platform can
• 17:51
  Speaker 12: do this. I can't get the data out of it.
• 17:54
  Speaker 3: Yeah. Yeah, that's frustrating.
• 17:56
  Speaker 2: And I've heard a lot about that with different workflow
• 17:59
  Speaker 2: platforms that are hitting top of pharmacy management systems. So
• 18:03
  Speaker 2: that's kind of like the common denominator that I'm thinking of,
• 18:09
  Speaker 2: what is it? Is it the pharmacy management system?
• 18:12
  Speaker 3: Are you going to.
• 18:13
  Speaker 2: The theragies or the assembia ones or the key centrics
• 18:17
  Speaker 2: or whatever, and saying, hey, let us put this cassim
• 18:21
  Speaker 2: thing on top of this system to really augment and
• 18:25
  Speaker 2: to start encapsulating everything that's the ecosystem of a disease
• 18:29
  Speaker 2: state that you're concentrating on.
• 18:30
  Speaker 8: Correct, yep.
• 18:31
  Speaker 12: And it's getting it's getting that data from those systems
• 18:34
  Speaker 12: into a usable state for the pharmacy, right, So pulling
• 18:37
  Speaker 12: that out and then leveraging that at the pharmacy level
• 18:39
  Speaker 12: so that they can integrate with all their parties to
• 18:42
  Speaker 12: have the best of both worlds, right, and build a
• 18:44
  Speaker 12: best of breed pharmacy.
• 18:46
  Speaker 13: And that's really what everyone should one ecosystem, right. We
• 18:48
  Speaker 13: want to.
• 18:49
  Speaker 12: Enable the patients and the providers and everybody else in
• 18:51
  Speaker 12: the ecosystem to have an easier life, to have better outcomes.
• 18:55
  Speaker 12: And you can't do that if there's just these blockers
• 18:57
  Speaker 12: and barriers and how how do you leverage AI? At
• 18:59
  Speaker 12: that point, you're going to bring in these tools and
• 19:01
  Speaker 12: the next thing you know, you're going to say, hey,
• 19:02
  Speaker 12: this is supposed to.
• 19:03
  Speaker 13: Be a fifty percent efficiency game. It doesn't integrate into
• 19:05
  Speaker 13: my workflow. I'm worse than I lost before.
• 19:07
  Speaker 2: Yeah, and things are more complex and you have to
• 19:11
  Speaker 2: sign in user name password into.
• 19:13
  Speaker 3: Your eighteenth system of the day.
• 19:14
  Speaker 2: Yep, it's crazy. Chris, this has been a good time.
• 19:18
  Speaker 2: Thank you so much for giving us some insights as
• 19:20
  Speaker 2: to what Cassie and RX is doing.
• 19:22
  Speaker 3: Thanks so much for being part of the NSP podcast.
• 19:25
  Speaker 13: Okay, thank you.
• 19:30
  Speaker 3: Hi.
• 19:30
  Speaker 5: This is Hailey Burgess and coming in live from the
• 19:33
  Speaker 5: NASP podcast.
• 19:37
  Speaker 3: Hailey, it's wonderful to have you on the show. Welcome,
• 19:40
  Speaker 3: thank you, thanks for having us.
• 19:41
  Speaker 5: What an amazing show. This is my first time here,
• 19:44
  Speaker 5: Oh my goodness, and I am so enjoying it. So
• 19:48
  Speaker 5: well executed, the content is tremendous and I had an
• 19:52
  Speaker 5: opportunity to present yesterday. A great crowd that's coming in
• 19:56
  Speaker 5: with really good feedback on the conversations.
• 19:58
  Speaker 3: That's wonderful.
• 20:00
  Speaker 2: The NEASP Booth for those that didn't get to come
• 20:02
  Speaker 2: to the conference here in Denver is right across from
• 20:05
  Speaker 2: the anovl On booth, So it was fun to see
• 20:07
  Speaker 2: you guys over there and you've been so busy.
• 20:10
  Speaker 5: Yes, this is really good for us. We invest a
• 20:13
  Speaker 5: lot of time and effort in preparing for this show,
• 20:16
  Speaker 5: reaching out in advance, getting our customers and prospects to
• 20:20
  Speaker 5: the booth. And a Novlon has many products that support
• 20:24
  Speaker 5: specialty pharmacy.
• 20:26
  Speaker 3: Well, let's dig into that.
• 20:28
  Speaker 2: So tell me about yourself and what role a Novalon
• 20:31
  Speaker 2: plays in specialty pharmacy.
• 20:33
  Speaker 7: Yeah.
• 20:33
  Speaker 5: So I'm a pharmacist by training, so very fond of
• 20:37
  Speaker 5: the profession obviously, and for a Novalon, I'm an SVP
• 20:42
  Speaker 5: of the care management portfolio. And what that means is
• 20:45
  Speaker 5: my products are software as a service clinical surveillance, so
• 20:51
  Speaker 5: we work directly with hospitals, ambulatory care, specialty pharmacies and
• 20:57
  Speaker 5: support their clinical pharmacy workflows. And I'll tell you more
• 21:01
  Speaker 5: about that in a minute. But we have other products also,
• 21:03
  Speaker 5: so safety Surveillance, which is an event reporting platform but
• 21:08
  Speaker 5: also electronic triggers looking for those things you don't know
• 21:11
  Speaker 5: about the safety events that are occurring. We also have
• 21:15
  Speaker 5: script med, which is an end to end pharmacy verification
• 21:20
  Speaker 5: dispensing platform that's a big hit here.
• 21:24
  Speaker 2: I feel like I'm getting old by admitting this, but
• 21:26
  Speaker 2: when I started in pharmacy over twenty years ago, I
• 21:30
  Speaker 2: would hear it. I would hear something at a pharmacy
• 21:33
  Speaker 2: conference that would be a buzzword, and then we really
• 21:36
  Speaker 2: wouldn't see any application for maybe a year or two out.
• 21:40
  Speaker 2: That is not the case in AI, because AI is
• 21:43
  Speaker 2: happening here and now, and technology and rule based AI
• 21:48
  Speaker 2: from the electronic health record integration to clinical surveillance and
• 21:53
  Speaker 2: reshaping the way specially pharmacies support patient care.
• 21:57
  Speaker 3: Talk to us about the complexities of that.
• 22:00
  Speaker 5: For twenty years, our team has been using rule based
• 22:03
  Speaker 5: AI before it was cool, so we have truly perfected
• 22:08
  Speaker 5: what that looks like on the clinical side of the workflow.
• 22:12
  Speaker 5: So we take all that rich electronic health record data
• 22:16
  Speaker 5: anything you can send us, and we put that through
• 22:20
  Speaker 5: our advanced rules engine. So think of if then statements,
• 22:24
  Speaker 5: algorithmic care and so it's very precise of the information
• 22:30
  Speaker 5: that we're giving back to clinicians in near real time,
• 22:33
  Speaker 5: think every ten minutes or so. As soon as that
• 22:35
  Speaker 5: electronic health record is updated micro labs weights, then it
• 22:42
  Speaker 5: processes through our algorithms and pushes to the clinician to
• 22:48
  Speaker 5: intervene in real time. So it's an exciting platform. And
• 22:52
  Speaker 5: I was the business owner of this tool on the
• 22:55
  Speaker 5: customer side for about ten years, so I've seen it
• 22:59
  Speaker 5: absolute utely transform pharmacy services so that each patient is
• 23:04
  Speaker 5: taking care of twenty four to seven regardless of who's
• 23:08
  Speaker 5: on staff or which pharmacist is there. Your coverage is there,
• 23:12
  Speaker 5: so you're protecting patients. And some of the outcomes that
• 23:15
  Speaker 5: we've seen is a doubled productivity for pharmacists right, a
• 23:19
  Speaker 5: double in the number of clinical interventions preimpost sixty percent
• 23:24
  Speaker 5: reduction in adverse drug events that were coded. That means
• 23:29
  Speaker 5: patients that don't suffer from harm.
• 23:31
  Speaker 3: Right.
• 23:31
  Speaker 5: Doctor Bates, his study in New England Journal Medicine in
• 23:35
  Speaker 5: twenty twenty three talks to us about patient safety and
• 23:37
  Speaker 5: preventable harm. What was the biggest bucket medications? So preventable harm.
• 23:44
  Speaker 5: Forty percent of the bucket of what's preventable is medication management.
• 23:48
  Speaker 5: And we need good systems that protect patients and that's
• 23:52
  Speaker 5: where our surveillance comes in. Supporting those clinicians, integrating with
• 23:57
  Speaker 5: their workflow and creating this really seamless ability for them
• 24:02
  Speaker 5: to do what they do well, intervene quickly, protect people,
• 24:06
  Speaker 5: and bring outcomes. And not only that, it protects the clinician.
• 24:10
  Speaker 5: No one wants to make a mistake, so we're constantly
• 24:14
  Speaker 5: monitoring assuring they don't miss anything.
• 24:16
  Speaker 2: Yeah, systems and consistency help us to present what's happening
• 24:22
  Speaker 2: in the status quo so that we can look to
• 24:24
  Speaker 2: the future of how we can improve upon this, and
• 24:27
  Speaker 2: then all that data that's been collected can be leveraged
• 24:30
  Speaker 2: to actually make that determination. This leads me to my
• 24:33
  Speaker 2: last question, and that's an aspect of the NASP and
• 24:37
  Speaker 2: what I get excited about coming to the annual event.
• 24:40
  Speaker 2: This is our first fifth time covering this event is
• 24:45
  Speaker 2: innovation and what the future looks like. So, looking ahead,
• 24:48
  Speaker 2: what do you see as the biggest opportunities and challenges
• 24:51
  Speaker 2: for specialty pharmacy Let's say in the next three or
• 24:53
  Speaker 2: five years.
• 24:54
  Speaker 5: Right, there are so many unfortunately, especially in uncertainty. Ye,
• 25:00
  Speaker 5: we're thinking about affordability and then access to patients. These
• 25:04
  Speaker 5: medications are very expensive, and the concern in policy and
• 25:09
  Speaker 5: regulation where are we going to land in the uninsured,
• 25:13
  Speaker 5: and what that population looks like, and how those patients
• 25:16
  Speaker 5: can pay those copays, can pay the co insurance and
• 25:20
  Speaker 5: continue to get the medications that we need that they
• 25:24
  Speaker 5: have to have that are life saving for them. I
• 25:26
  Speaker 5: think that's one of the biggest hurdles that are coming
• 25:29
  Speaker 5: and so how do we support that. We can support
• 25:32
  Speaker 5: that with tools right We've got our AI surveillance that's
• 25:36
  Speaker 5: looking for the right person, the right patient at the
• 25:39
  Speaker 5: right time, and then affordability in real time looking at
• 25:43
  Speaker 5: that prior authorization. Helping patients through that is a complicated process.
• 25:49
  Speaker 5: It takes a lot of time and effort, and patients
• 25:52
  Speaker 5: don't know how to navigate that. We've got to make
• 25:54
  Speaker 5: it easier for them. And you're seeing more and more
• 25:57
  Speaker 5: these announcements around AI and prior authorization and revenue cycle management,
• 26:03
  Speaker 5: and a novelon has those products, and we're partnering with
• 26:07
  Speaker 5: Google right now on prior authorization and using this really
• 26:12
  Speaker 5: slick AI model.
• 26:13
  Speaker 3: So we are on.
• 26:14
  Speaker 5: Top of this and really looking forward to helping the
• 26:17
  Speaker 5: patients navigate this, whether it's from order verification and that
• 26:22
  Speaker 5: process with script met or our clinical surveillance that's assuring
• 26:26
  Speaker 5: twenty four to seven patients are getting what they receive
• 26:29
  Speaker 5: in the right time, in the right way and protecting them.
• 26:33
  Speaker 5: And then through the billing cycled with revenue cycle management
• 26:36
  Speaker 5: and prior AFE. So that's what I appreciate about being
• 26:39
  Speaker 5: part of a novlon is that we have that full
• 26:41
  Speaker 5: suite of products that really support patients in specialty care
• 26:45
  Speaker 5: in acute ambulatory. It really doesn't matter the setting, but
• 26:48
  Speaker 5: specialty is very near and dear these ultra rare diseases.
• 26:55
  Speaker 5: Understanding what that looks like and caring for those patients,
• 26:59
  Speaker 5: it's a really special pop and oncology as well. So
• 27:02
  Speaker 5: I feel very privileged to be in this space.
• 27:05
  Speaker 2: We're privileged to have you on the NSP podcast helping
• 27:08
  Speaker 2: us at the coverage of the twenty twenty five show.
• 27:11
  Speaker 2: Thank you so much, Haley for being part of this
• 27:14
  Speaker 2: my pleasure.
• 27:14
  Speaker 5: Thank you so much for having me.
• 27:18
  Speaker 14: Hey.
• 27:18
  Speaker 15: This is Eric Robinson from dose Spot and you're listening
• 27:21
  Speaker 15: to the NASP podcast.
• 27:22
  Speaker 16: Hey, this is Wilson Town from dough Spot and you
• 27:25
  Speaker 16: are listening to the NASP podcast.
• 27:29
  Speaker 2: Hey, we are here with a double header team from
• 27:33
  Speaker 2: dose Spot.
• 27:34
  Speaker 3: Eric.
• 27:36
  Speaker 2: Now I can't remember your name. You can't do that
• 27:38
  Speaker 2: to me. Harry Wilson. Welcome to the show, the NSP podcast.
• 27:43
  Speaker 2: Hey Wilson, Why is it important to be here at
• 27:46
  Speaker 2: the NESP.
• 27:47
  Speaker 16: I think NASP is just a great place for all
• 27:52
  Speaker 16: these stakeholders in the specialties face to a get FaceTime,
• 27:55
  Speaker 16: but also be learn about all the different solutions that
• 27:59
  Speaker 16: are out there, especially like I would say, with the
• 28:02
  Speaker 16: advent of AI and some of the new tech that's
• 28:04
  Speaker 16: coming out, just seeing how all the pieces fit together.
• 28:06
  Speaker 16: I think it's still such a valuable experience to get
• 28:08
  Speaker 16: exposure all that all in one place.
• 28:11
  Speaker 2: Aron, what's the evolution of dough Spot Like, take us
• 28:14
  Speaker 2: through kind of the inception and then why you're part
• 28:17
  Speaker 2: of specialty pharmacy?
• 28:18
  Speaker 15: Yeah, so absolutely so. Right now do Spots started as
• 28:22
  Speaker 15: a prescriber. We're still an e prescriber right when we
• 28:24
  Speaker 15: started in the retail space. We have a lot of
• 28:26
  Speaker 15: different clients in dental retail, and what we're looking to
• 28:30
  Speaker 15: do is move into specialty. There was a talk earlier
• 28:33
  Speaker 15: about specialty and how seventy five percent of new drugs
• 28:36
  Speaker 15: are specialty drugs. Specialty pharmacies are going to move away
• 28:40
  Speaker 15: from being big block pharmacies and back into like the
• 28:44
  Speaker 15: more I guess specialized specialty, you know, focus on dermatology,
• 28:48
  Speaker 15: your rare diseases, and how do we break into that
• 28:50
  Speaker 15: space so that we can solve the problems at the
• 28:54
  Speaker 15: point of prescriber instead of somewhere else in the workflow.
• 28:59
  Speaker 2: Rollson, you and I were talking talking about prior authorization,
• 29:01
  Speaker 2: the bottlenecks of getting prescriptions through. Talk to us about
• 29:05
  Speaker 2: some of the solutions that you've been a part of
• 29:07
  Speaker 2: and forming.
• 29:08
  Speaker 8: Yeah.
• 29:08
  Speaker 16: Absolutely so someone specialty pharmacy, worked in sespecialty pharmacy for
• 29:13
  Speaker 16: a long time and was in the tech space, and
• 29:15
  Speaker 16: especially pharmacy. I think especially pharmacy and pharmacists in general
• 29:19
  Speaker 16: are used to absorbing all of the problems so things
• 29:24
  Speaker 16: of Okay, we will help do all the benefit investigation,
• 29:27
  Speaker 16: we will help do all the prior authorization coordination. We're
• 29:30
  Speaker 16: going to do a lot of the legwork so that
• 29:33
  Speaker 16: patients can get the care that they need. You know,
• 29:35
  Speaker 16: I think as technology is changing, what we don't want.
• 29:39
  Speaker 8: Is to increase any of the abrasion.
• 29:41
  Speaker 16: Between a pharmacist and of physician and prescriber. We're looking
• 29:44
  Speaker 16: to do is okay, what if we could surface more
• 29:48
  Speaker 16: solutions at that point of prescribing. As Eric mentioned, so
• 29:52
  Speaker 16: a great example is like we can do a real
• 29:54
  Speaker 16: time benefit check on the patient at the point of prescribing.
• 29:57
  Speaker 16: We if we know a drug is a limited distribution
• 30:00
  Speaker 16: drug that can only go one place, we can surface
• 30:03
  Speaker 16: that at the point of prescribing. And there's just a
• 30:05
  Speaker 16: lot of problems that I think we can provide information
• 30:09
  Speaker 16: both to the prescriber and the patient at the right time.
• 30:12
  Speaker 16: That'll smooth a little bit of that out. And I
• 30:15
  Speaker 16: think pharmacy is still going to be that catch all.
• 30:17
  Speaker 16: I mean, we're still going to ultimately be that safety
• 30:20
  Speaker 16: net to make sure patients get medications, but you know,
• 30:24
  Speaker 16: a lot of that can be surfaced earlier on the
• 30:27
  Speaker 16: process and hopefully it'll make life easier for everyone.
• 30:30
  Speaker 3: All right, Eric, the important of partnerships.
• 30:32
  Speaker 2: One of the aspects of ANSP is bringing together vendors
• 30:35
  Speaker 2: who work together to help build efficiencies, operations, compliancy for
• 30:40
  Speaker 2: our specialty pharmacies.
• 30:41
  Speaker 3: Talk to me about some of your partners.
• 30:44
  Speaker 15: Yeah, so we have some of the big players, right.
• 30:47
  Speaker 8: So for a prior organization, we are connected to cover
• 30:51
  Speaker 8: my MIDS.
• 30:51
  Speaker 15: We work with the PDMP teams we are very connected with. Actually,
• 30:58
  Speaker 15: one of the interesting things is that we are here
• 31:00
  Speaker 15: year to look for more specialty partners nice, yes, right,
• 31:03
  Speaker 15: so that we can work at Do we solve our
• 31:06
  Speaker 15: problems at the hubs at the point of the hub?
• 31:08
  Speaker 15: Do we solve it directly with the specialty pharmacy. Our
• 31:12
  Speaker 15: main focus here is to expand our partnerships in specialty
• 31:16
  Speaker 15: pharmacy so that we don't need to break off with
• 31:20
  Speaker 15: like some tertiary or other team that is farther away
• 31:24
  Speaker 15: down the line from specialty pharmacy, and so that we
• 31:26
  Speaker 15: can just keep that workflow as streamlined as possible between prescriber, prescriber,
• 31:31
  Speaker 15: patient and pharmacy.
• 31:33
  Speaker 2: Eric Wilson, it's been good to talk to both of
• 31:37
  Speaker 2: you at dose Spot.
• 31:39
  Speaker 3: I'd love to have you back on this week in Pharmacy.
• 31:41
  Speaker 8: Yeah, that'd be great.
• 31:42
  Speaker 16: Thank you so much, Todd, And it's always a pleasure
• 31:44
  Speaker 16: to be on your podcast.
• 31:46
  Speaker 3: Oh yeah, thank you, thank you so much.
• 31:47
  Speaker 7: Eric.
• 31:52
  Speaker 17: Hey, this is Harry Travis, president of the Travis Group,
• 31:55
  Speaker 17: and you're listening to the Pharmacy podcast at NASP.
• 32:01
  Speaker 2: Harry Travis back on the NASP podcast here at the
• 32:05
  Speaker 2: NASP twenty twenty five.
• 32:06
  Speaker 3: Harriet's so good to see you.
• 32:07
  Speaker 8: It is great to see you too, Todd. It is
• 32:10
  Speaker 8: just great to be here.
• 32:11
  Speaker 17: And I'm glad I ran into you here me.
• 32:14
  Speaker 3: Too, all right.
• 32:15
  Speaker 2: I had the ability the opportunity to jump on something
• 32:19
  Speaker 2: that you're doing, which is an RX roundtable, which brings
• 32:22
  Speaker 2: these insights and minds that are really reshaping pharmacy and
• 32:26
  Speaker 2: so many different sectors. You and I, though, have this
• 32:29
  Speaker 2: attraction to specialty pharmacy.
• 32:31
  Speaker 3: That's how I met you years ago.
• 32:34
  Speaker 8: That's right.
• 32:34
  Speaker 2: So what's happening from a novel perspective the innovation of
• 32:39
  Speaker 2: specialty and I know that you have a very keen
• 32:42
  Speaker 2: interest in artificial intelligence impact on specialty pharmacy.
• 32:47
  Speaker 17: You're right, And my number one objective for this meeting
• 32:52
  Speaker 17: is to focus as much of my energy and attention
• 32:56
  Speaker 17: on any presentation, any company, any individual it's doing work
• 33:01
  Speaker 17: on AI and pharmacy or AI and pharmacy, benefit management,
• 33:06
  Speaker 17: any aspect of the business. I'm trying to take a personal,
• 33:11
  Speaker 17: like twenty thousand foot view of everything that's going on.
• 33:15
  Speaker 17: There are plenty of people that are working in AI
• 33:18
  Speaker 17: companies that are down at the ground level trying to
• 33:22
  Speaker 17: solve problems with prior off medication, therapy management, patient access,
• 33:28
  Speaker 17: revenue cycle management, workflow management.
• 33:30
  Speaker 8: Three forty B.
• 33:32
  Speaker 17: I can't be an expert in all of that, but
• 33:34
  Speaker 17: i can see how it's all fitting together, and I'm
• 33:39
  Speaker 17: using the RX Roundtable my expert network to help those
• 33:43
  Speaker 17: companies kind of navigate the greater pharmacy landscape.
• 33:48
  Speaker 2: What about AI specifically, have you seen out there impacting
• 33:52
  Speaker 2: efficiencies in pharmacy workflow or data analytics. I've heard about
• 33:59
  Speaker 2: audit protection using AI. Like talk to us about some
• 34:03
  Speaker 2: of the specifics you've seen.
• 34:05
  Speaker 17: I've seen a fair amount of examples of call it
• 34:11
  Speaker 17: advanced robotic process automation. You know, RPA is really old,
• 34:16
  Speaker 17: but now RPA can be a lot smarter to understand
• 34:20
  Speaker 17: what it's looking at on a screen and kind of
• 34:23
  Speaker 17: complete the task. So as you would expect, there's a
• 34:28
  Speaker 17: lot of the simpler tasks that you would have a
• 34:30
  Speaker 17: technician or patient services rep do, look up this information,
• 34:35
  Speaker 17: move it from this database over to that database. I
• 34:39
  Speaker 17: had thousands of these good folks working for me at
• 34:43
  Speaker 17: all my various jobs in the past, so that aspect
• 34:48
  Speaker 17: of the administrative kind of the benefit management, benefit verification
• 34:53
  Speaker 17: prior authorization. So much of the process of filling a
• 34:57
  Speaker 17: prescription is nothing more than and I don't mean to
• 35:01
  Speaker 17: minimize it, but when you look at it in an
• 35:03
  Speaker 17: engineering perspective, it's nothing more than you have a question
• 35:06
  Speaker 17: in front of you, and you know the answer is
• 35:09
  Speaker 17: out there in a database.
• 35:10
  Speaker 8: You got to get it and you got to complete
• 35:13
  Speaker 8: the form.
• 35:14
  Speaker 17: No one is making up any information in any pharmacy.
• 35:18
  Speaker 17: There's no creativity, you know, in terms of getting a
• 35:22
  Speaker 17: prescription fill. So that fundamental data transfer process at kind
• 35:29
  Speaker 17: of the early intake stage, benefit verification stage of the
• 35:33
  Speaker 17: prescription is where I'm seeing a lot of traction and
• 35:36
  Speaker 17: you're starting to see a number of the voice agents
• 35:41
  Speaker 17: start to take root. You know, I think it's going
• 35:43
  Speaker 17: to be a while before everybody gets really comfortable talking
• 35:47
  Speaker 17: to all of these agents. But the one thing I
• 35:50
  Speaker 17: think everyone needs to realize is that the agent that
• 35:54
  Speaker 17: you're talking to now, or the AI tool that you're
• 35:57
  Speaker 17: using now is the worst tool you will ever use.
• 36:01
  Speaker 8: These are only going to get smarter and faster.
• 36:05
  Speaker 3: True, it's true.
• 36:07
  Speaker 2: I've talked to Nested Knowledge, I've talked to Corsini, I've
• 36:12
  Speaker 2: talked to a couple organizations who are giving me actual
• 36:16
  Speaker 2: examples how artificial intelligence is being planted and used and
• 36:21
  Speaker 2: what the future looks like, and the query the quick
• 36:26
  Speaker 2: excess of data that's being extracted from these databases put
• 36:29
  Speaker 2: into these AI engines. It's exciting because it's going to
• 36:33
  Speaker 2: take a lot of the pains out of these operations
• 36:36
  Speaker 2: where two years ago, five years ago, with prior authorization
• 36:40
  Speaker 2: or auditing or something, it's going to be seamless now
• 36:44
  Speaker 2: because you're.
• 36:44
  Speaker 3: Going to allow AI to do it right.
• 36:46
  Speaker 2: Harry, when it comes to AI and specialty, I hear
• 36:50
  Speaker 2: so many different things. There's a lot of chatter here
• 36:53
  Speaker 2: at the NASP twenty twenty five.
• 36:56
  Speaker 3: What are you observing?
• 36:58
  Speaker 17: I am trying to think as positively as I think.
• 37:02
  Speaker 17: What I'm observing is lots of interest, lots of desire
• 37:08
  Speaker 17: to eliminate tasks with AI so that people can do more.
• 37:15
  Speaker 17: But there needs to be an answer to Okay, if
• 37:18
  Speaker 17: there's more time available, what are we going to do
• 37:20
  Speaker 17: with it now? In some cases the workload is really heavy,
• 37:24
  Speaker 17: so it just makes things better, But ultimately there might
• 37:29
  Speaker 17: be some really free time, true free time derived and
• 37:34
  Speaker 17: in that case, I think the interesting intersection is the
• 37:38
  Speaker 17: intersection of the productivity gains of AI with the standard
• 37:44
  Speaker 17: of practice or full practice authority gains that are coming
• 37:48
  Speaker 17: in certain states for pharmacy, where pharmacists are achieving full
• 37:52
  Speaker 17: practice authority in states like Idaho, Iowa, Montana. I think Colorado.
• 37:59
  Speaker 17: Double check me on those, but I think they're the
• 38:01
  Speaker 17: ones that are at the forefront of this, and AI
• 38:04
  Speaker 17: might be coming at the perfect time that all of
• 38:07
  Speaker 17: a sudden, you have time available. You don't have to
• 38:09
  Speaker 17: add more staff, but you can do a whole heck
• 38:12
  Speaker 17: of a lot more, and the regulations have it allowed.
• 38:15
  Speaker 8: Now we need to make.
• 38:16
  Speaker 17: Sure pharmacists get paid for it, but getting the regulatory
• 38:20
  Speaker 17: burden out of the way is the very first step.
• 38:23
  Speaker 17: So there really could be a really positive intersection of
• 38:26
  Speaker 17: the technology and the trend toward full practice authority.
• 38:32
  Speaker 3: Harry, talk to us.
• 38:33
  Speaker 2: You mentioned earlier in the interview about the ARCS roundtable.
• 38:36
  Speaker 2: Talk to our listeners about how to get engaged with that.
• 38:39
  Speaker 17: Yeah, So if you are a listener, if you are
• 38:43
  Speaker 17: a solopreneur, independent consultant, maybe retired semi retired, on a
• 38:49
  Speaker 17: board an advisor role, and you're looking to essentially continue
• 38:54
  Speaker 17: to grow and grow your knowledge, grow your network.
• 38:57
  Speaker 8: Grow your business.
• 38:59
  Speaker 17: The ARCS around Table is a group of independent solorepreneurs
• 39:03
  Speaker 17: with deep experience and pharmacy operations and pharmacy benefit management
• 39:08
  Speaker 17: kind of healthcare operations, but focused.
• 39:10
  Speaker 8: On the pharmacy side.
• 39:12
  Speaker 17: And it's an organization that we meet virtually every week
• 39:17
  Speaker 17: four o'clock on Tuesday as our standard time. Two thirds
• 39:21
  Speaker 17: of our sessions are with early stage companies coming to
• 39:24
  Speaker 17: tell us about themselves, typically in the pharmacy tech space,
• 39:28
  Speaker 17: a lot of AI companies right now, and then we
• 39:32
  Speaker 17: decide whether there's a fit. It's almost like a matchmaking
• 39:36
  Speaker 17: networking session that we have with these companies. And the
• 39:39
  Speaker 17: other third of the sessions are what we call hot
• 39:42
  Speaker 17: topics or hot issue sessions, where one of the members
• 39:47
  Speaker 17: could be a subject matter expert in three four to
• 39:50
  Speaker 17: B compounding, pharmacy, fertility, pharmacy, prescription, digital therapeutics.
• 39:56
  Speaker 8: And it's just our way of kind as.
• 39:59
  Speaker 17: A group, keeping together and staying in kind of in network,
• 40:04
  Speaker 17: if you will. And the website is THERX roundtable dot com.
• 40:09
  Speaker 8: I love it.
• 40:10
  Speaker 2: Harry Travis an important voice in specialty pharmacy. You and
• 40:15
  Speaker 2: I have been documenting the profession of specialty pharmacy for
• 40:20
  Speaker 2: a long time. We always appreciate your insights.
• 40:22
  Speaker 8: Likewise, you've been doing a great job.
• 40:24
  Speaker 9: Keep it up, Hey, Shout out to our specialty pharmacists
• 40:30
  Speaker 9: and pharmacy owners and pharmacy operators out there concentrating on
• 40:35
  Speaker 9: rare disease specialty pharmacy specific disease state management. Do you
• 40:39
  Speaker 9: understand what the NASP does in the power that it
• 40:43
  Speaker 9: brings to our profession, the protections that it brings, the
• 40:47
  Speaker 9: education that it brings. Vetter on state advocacy, Government Affairs
• 40:51
  Speaker 9: Committee workshops, grassroots advocacy education including abstract and poster programs.
• 40:58
  Speaker 9: The CMR a NASP partner, Journal Education centered Presenter, Educational
• 41:06
  Speaker 9: Committee and work groups.
• 41:07
  Speaker 3: The NASP is leading the Certified.
• 41:10
  Speaker 2: Specialty Pharmacist the csp cretentials. Look into the NASP. Reach
• 41:17
  Speaker 2: out to one of their members. We're excited to be
• 41:20
  Speaker 2: here at the NASP twenty twenty five. Ethan Wynn, Doctor
• 41:25
  Speaker 2: Wynn at the NASPA twenty twenty five.
• 41:28
  Speaker 3: Thanks for being on the show. Absolutely pleasure.
• 41:31
  Speaker 2: Hey talk to us about SPHINX strategies. I talked to
• 41:34
  Speaker 2: your colleague Vic. He's just on a ball of ideas
• 41:38
  Speaker 2: and energy and innovation of where specialty pharmacy's going.
• 41:41
  Speaker 3: We talked about AI. Give us your perception of.
• 41:46
  Speaker 2: About the industry and where you guys fit into specialty pharmacy.
• 41:49
  Speaker 14: Yeah, we started out as a consultant firm and actually
• 41:53
  Speaker 14: SPH Strategies was one of my consultants when I was
• 41:55
  Speaker 14: going through my career path as specialty pharmacists getting a credation,
• 42:02
  Speaker 14: So a lot of work we helped with small to
• 42:04
  Speaker 14: mid size you know, specialty pharmacies through their credation process
• 42:08
  Speaker 14: and actually making sure they understand the value of it.
• 42:10
  Speaker 14: A lot of folks think, okay, it's a ticket to
• 42:12
  Speaker 14: enter and get PBM contracts whatnot. But that's just the
• 42:16
  Speaker 14: first initial step of understanding what the value is. You
• 42:20
  Speaker 14: spoke about AI data is big. How do you continue
• 42:23
  Speaker 14: to develop that value prop for the payers for your providers?
• 42:28
  Speaker 14: And that's really it's going to develop the story as
• 42:30
  Speaker 14: you kind of expand your business to have more access
• 42:35
  Speaker 14: to limited distribution.
• 42:36
  Speaker 13: Drugs for example.
• 42:36
  Speaker 14: Right, So understanding how it all fits together, that's kind
• 42:40
  Speaker 14: of what we've done best. And you know, I'm on
• 42:43
  Speaker 14: the operation side, So when I go in and visit
• 42:46
  Speaker 14: our clients operations, I look for ways to drive efficiencies.
• 42:49
  Speaker 14: So whether that's you know, giving them options to look
• 42:52
  Speaker 14: at what technologies they're utilizing, and then from the pharmacists perspective,
• 42:56
  Speaker 14: because I'm a pharmacist myself, then understanding how to apply
• 42:58
  Speaker 14: and implement.
• 42:59
  Speaker 12: Right.
• 43:00
  Speaker 14: So we say things on paper with policies and procedures,
• 43:03
  Speaker 14: but how do you actually put that into process?
• 43:05
  Speaker 2: Yeah, that makes sense, and how what that impact means
• 43:08
  Speaker 2: for client touch, patient touch follow up and in disease
• 43:14
  Speaker 2: state management.
• 43:15
  Speaker 14: Absolutely, and as you scale and grow your business, you're
• 43:18
  Speaker 14: going to go through those growing pains, right, So how
• 43:20
  Speaker 14: do you continue to maintain a high level of quality
• 43:22
  Speaker 14: of service for your patients as you're updating all of
• 43:25
  Speaker 14: these new procedures trying to stay compliant, And sometimes that's
• 43:29
  Speaker 14: not about checking the checklist, right, You really want to
• 43:32
  Speaker 14: continue to think about what, in the end are you
• 43:34
  Speaker 14: doing better for the patients.
• 43:36
  Speaker 2: There's a lot of conferences you could be going to.
• 43:39
  Speaker 2: We go about between eight and twelve. Sometimes we had,
• 43:43
  Speaker 2: Oh good goodness, in July we went to three in
• 43:46
  Speaker 2: one month.
• 43:46
  Speaker 3: It was crazy. So I have to be very specific.
• 43:49
  Speaker 2: Of which ones I show up at because it's not
• 43:52
  Speaker 2: so much the money.
• 43:53
  Speaker 3: Although they're expensive. It's the time.
• 43:55
  Speaker 2: Yes, So how are you picking conferences and why do
• 43:58
  Speaker 2: you choose to come to n.
• 44:00
  Speaker 13: Yeah, I don't envy you.
• 44:01
  Speaker 14: I used to go to at least one a month myself,
• 44:05
  Speaker 14: and when I was starting my career in specialty, I
• 44:07
  Speaker 14: felt that that was a necessity to go in and
• 44:11
  Speaker 14: network and really talk to the folks that are in
• 44:13
  Speaker 14: the industry doing it in real time. And the reason
• 44:16
  Speaker 14: why I'm so proud and so happy about what I'm
• 44:19
  Speaker 14: seeing here at NAS as it's growing, it's really the
• 44:21
  Speaker 14: opportunities that not just the way they set up the programs,
• 44:25
  Speaker 14: but you know the topics. They really those committees that
• 44:27
  Speaker 14: develop all these speaking arrangements and whatnot and find the
• 44:31
  Speaker 14: right speakers do a really great job of sourcing what
• 44:34
  Speaker 14: the community, what the industry, what all the stakeholders are
• 44:37
  Speaker 14: looking to find at a conference. So it's yes, it's fun,
• 44:40
  Speaker 14: it's a show, it's nice to be in a different city.
• 44:42
  Speaker 14: But at the same time, you're going to come here
• 44:44
  Speaker 14: with the expectation that you're going to meet someone and
• 44:46
  Speaker 14: going to learn something, and.
• 44:47
  Speaker 13: The community itself is willing to share.
• 44:49
  Speaker 14: I think I see that a lot more so here
• 44:51
  Speaker 14: at this partial conference than maybe some of the other ones.
• 44:54
  Speaker 3: Yeah, I picked that up as well.
• 44:55
  Speaker 2: There's a little bit more collaboration and driving comm verticals
• 45:01
  Speaker 2: that people know, Hey, I'm in tech or I'm in
• 45:03
  Speaker 2: automation ARM and prior authorization ARM in something that we
• 45:06
  Speaker 2: know as a challenge and using that mind share is important.
• 45:10
  Speaker 3: It's a good thing.
• 45:12
  Speaker 2: So next year we'll be in Maryland Baltimore area. Talk
• 45:19
  Speaker 2: to me about the next maybe if you can give
• 45:21
  Speaker 2: me any things that Sphinx is working on for the
• 45:24
  Speaker 2: next year, the next twelve months.
• 45:25
  Speaker 14: Yeah, you may have heard it from my colleague. I mean,
• 45:27
  Speaker 14: we're on the bleeding edge when it comes to servicing
• 45:30
  Speaker 14: our clients, so we're always looking for the next thing
• 45:32
  Speaker 14: as well. So we won't kind of burst of bubble.
• 45:34
  Speaker 14: We'll save it for next year's conference. I'm sure we'll
• 45:36
  Speaker 14: be invited to speak on some topics. But yeah, AI
• 45:38
  Speaker 14: is going to be continuing to be an interesting topic
• 45:41
  Speaker 14: that's going to continue evolve. I'm sure there'll be more
• 45:43
  Speaker 14: updates about that. But we're also looking at how things
• 45:46
  Speaker 14: are changing with the new you know, with the current administration,
• 45:49
  Speaker 14: how policy is changing and affecting how we deliver certain
• 45:52
  Speaker 14: care plans and how that affects how we continue to
• 45:55
  Speaker 14: provide the kind of care that we provide in this
• 45:58
  Speaker 14: industry in specialty infusion Ethan.
• 46:01
  Speaker 2: This has been great. Thanks for talking with us on
• 46:03
  Speaker 2: the NESP podcast.
• 46:04
  Speaker 13: YEP, always the pressure.
• 46:05
  Speaker 2: Thank you, Heidi Pollick from Outcomes here at NESP.
• 46:14
  Speaker 3: It's so good to see.
• 46:15
  Speaker 7: You, Tod. We've got to stop meeting like this.
• 46:20
  Speaker 3: That's actually literally true. We're constantly meeting over microphones. I
• 46:26
  Speaker 3: love it.
• 46:28
  Speaker 2: There's aspects of your life in the pharmacy industry and
• 46:32
  Speaker 2: the growth of your career over the years, and part
• 46:35
  Speaker 2: of being part of an industry.
• 46:37
  Speaker 3: Is giving back.
• 46:38
  Speaker 2: I'm working on a certification called evidence based podcasting. What
• 46:42
  Speaker 2: that's going to do for assurance of someone listening knowing
• 46:46
  Speaker 2: that it's peer reviewed material, so that you could listen
• 46:48
  Speaker 2: to something that's just as good as a journal. You've
• 46:51
  Speaker 2: been part of another organization called Specially Pharmacy.
• 46:55
  Speaker 3: Certification of Board.
• 46:57
  Speaker 2: Yeah, and where the NESP has been this conduit of
• 47:01
  Speaker 2: what is the best of the best to set standards
• 47:04
  Speaker 2: to stick with evidence based practice.
• 47:07
  Speaker 3: Talk to us about this in this certification.
• 47:09
  Speaker 18: So as a pharmacist thirty six years, you know specialty
• 47:13
  Speaker 18: pharmacy is really coming into being now. I mean it
• 47:17
  Speaker 18: was just really in its infancy when I was still
• 47:19
  Speaker 18: behind the bench, and I can't imagine trying to take
• 47:24
  Speaker 18: care of specialty patients. The journey that these patients take
• 47:28
  Speaker 18: is so complex that you really, as a pharmacist, need
• 47:32
  Speaker 18: to make sure you have all the knowledge of that
• 47:36
  Speaker 18: disease state and how to care for that patient throughout
• 47:38
  Speaker 18: that very complex journey. And we at the Certification Board,
• 47:44
  Speaker 18: we're actually the organization that puts together those certification exams
• 47:48
  Speaker 18: for pharmacists to go out and become a CSP A
• 47:53
  Speaker 18: Certified Specialty Pharmacist. I mean, that's going to take you
• 47:57
  Speaker 18: to the next level as it relates to being able
• 47:59
  Speaker 18: to care for your patients. It's going to give you
• 48:02
  Speaker 18: a very high level of credibility with physicians, patients, and
• 48:09
  Speaker 18: the payers. So you know, you are finding the payers
• 48:12
  Speaker 18: now in order to get into these networks. They want
• 48:15
  Speaker 18: CSPs on staff at pharmacies. So it's just a really next,
• 48:20
  Speaker 18: great next step in your process as being a specialty pharmacist.
• 48:25
  Speaker 18: I highly recommend if those are the types of patients
• 48:27
  Speaker 18: you want to care for, take your knowledge to the
• 48:30
  Speaker 18: next level. Come over, visit our booth and learn how
• 48:33
  Speaker 18: to become a csp.
• 48:35
  Speaker 2: Where does the challenges lie in order to start to
• 48:40
  Speaker 2: develop standards for maybe a specific disease state that involves
• 48:45
  Speaker 2: an extremely expensive medication. There's timing to it, there's temperature
• 48:49
  Speaker 2: control to it, there's logistics, there's the last mile, there's adherents.
• 48:53
  Speaker 2: So talk to us about kind of dialing into some
• 48:55
  Speaker 2: of the specifics.
• 48:57
  Speaker 18: Yeah, as I've been here at this conference and sitting
• 49:00
  Speaker 18: in on a lot of workshops, it is really a
• 49:03
  Speaker 18: very complex journey that the pharmacist has to take with
• 49:05
  Speaker 18: their patients. We had case studies yesterday on did.
• 49:10
  Speaker 7: This medication pass?
• 49:11
  Speaker 18: You know, just the testing for the temperatures, things that
• 49:15
  Speaker 18: you know, I wouldn't know if I hadn't gone to
• 49:18
  Speaker 18: that next level of you know, getting a certification. So
• 49:22
  Speaker 18: that the journey is so complex that pharmacists have to
• 49:28
  Speaker 18: you know, know all those steps.
• 49:30
  Speaker 7: And that's what we do at you know, SPCB.
• 49:34
  Speaker 18: We help put all of that together in a in
• 49:37
  Speaker 18: a very educational package. We're going to help you learn
• 49:40
  Speaker 18: all the things you need to learn so that you
• 49:42
  Speaker 18: can successfully care for patients across multiple disease states. Because
• 49:46
  Speaker 18: it does differ across disease states as well. There's a
• 49:49
  Speaker 18: lot of complexities. So if you want to try to
• 49:52
  Speaker 18: take care of cancer patients and hepatitis patients and HIV patients,
• 49:56
  Speaker 18: you know, all these very unique, rare diseases, you can't
• 50:00
  Speaker 18: just it's not cookie cutter, and we can help you
• 50:04
  Speaker 18: understand that journey better than anyone else can.
• 50:08
  Speaker 2: The Specialty Pharmacy Certification. Reach out to the NASP get
• 50:12
  Speaker 2: more information on this. If you see Heidi on LinkedIn,
• 50:16
  Speaker 2: reach out to Heidi. She'll get you more information on it.
• 50:19
  Speaker 3: HEII. This has been special. Thanks for being part of this.
• 50:21
  Speaker 7: Always special to see you Todd.
• 50:23
  Speaker 3: Thank you